RecruitingPhase 3NCT06408259
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Sponsor: Bristol-Myers Squibb
Loma Linda, CA · Sacramento, CA · +10 more sites